Henry Schein, Inc. (NASDAQ:HSIC) – Equities research analysts at Piper Jaffray Companies lifted their Q3 2019 EPS estimates for shares of Henry Schein in a research note issued on Wednesday, August 7th. Piper Jaffray Companies analyst S. James now expects that the company will earn $0.86 per share for the quarter, up from their previous estimate of $0.84. Piper Jaffray Companies also issued estimates for Henry Schein’s Q4 2019 earnings at $0.98 EPS, Q1 2020 earnings at $0.86 EPS and Q2 2020 earnings at $0.90 EPS.
Other research analysts also recently issued reports about the company. Barrington Research restated a “buy” rating and set a $75.00 price objective on shares of Henry Schein in a report on Wednesday. Svb Leerink reissued a “market perform” rating and issued a $70.00 price objective (down previously from $75.00) on shares of Henry Schein in a research report on Wednesday, May 15th. Guggenheim started coverage on Henry Schein in a research note on Wednesday, April 17th. They set a “buy” rating and a $72.00 price objective for the company. Cleveland Research restated a “hold” rating on shares of Henry Schein in a research note on Thursday, May 2nd. Finally, Leerink Swann cut Henry Schein from an “outperform” rating to a “market perform” rating and lowered their price objective for the stock from $75.00 to $70.00 in a report on Wednesday, May 15th. They noted that the move was a valuation call. Seven analysts have rated the stock with a sell rating, nine have given a hold rating and four have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $73.64.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.83 by $0.01. Henry Schein had a return on equity of 16.67% and a net margin of 4.18%. The business had revenue of $2.45 billion for the quarter, compared to the consensus estimate of $2.48 billion. During the same period in the prior year, the business posted $1.04 earnings per share. The company’s quarterly revenue was up 5.7% compared to the same quarter last year.
A number of hedge funds and other institutional investors have recently made changes to their positions in HSIC. Geode Capital Management LLC grew its position in shares of Henry Schein by 8.3% in the 4th quarter. Geode Capital Management LLC now owns 2,105,314 shares of the company’s stock worth $165,038,000 after buying an additional 161,542 shares during the last quarter. Municipal Employees Retirement System of Michigan bought a new stake in shares of Henry Schein in the 4th quarter worth approximately $316,000. First Hawaiian Bank grew its position in shares of Henry Schein by 66.7% in the 1st quarter. First Hawaiian Bank now owns 650 shares of the company’s stock worth $39,000 after buying an additional 260 shares during the last quarter. Country Club Trust Company n.a. grew its position in shares of Henry Schein by 52.0% in the 1st quarter. Country Club Trust Company n.a. now owns 6,841 shares of the company’s stock worth $411,000 after buying an additional 2,340 shares during the last quarter. Finally, DNB Asset Management AS grew its position in shares of Henry Schein by 857.6% in the 1st quarter. DNB Asset Management AS now owns 203,510 shares of the company’s stock worth $12,233,000 after buying an additional 182,259 shares during the last quarter.
In other Henry Schein news, Vice Chairman James P. Breslawski sold 6,856 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $60.17, for a total value of $412,525.52. Following the sale, the insider now owns 249,046 shares of the company’s stock, valued at $14,985,097.82. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Paul Brons sold 1,758 shares of the business’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $70.96, for a total value of $124,747.68. Following the completion of the sale, the director now directly owns 17,582 shares in the company, valued at approximately $1,247,618.72. The disclosure for this sale can be found here. In the last three months, insiders sold 56,524 shares of company stock worth $3,984,949. 1.06% of the stock is owned by corporate insiders.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Story: Gap Up Stocks
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.